Needle Biopsy Market Overview
The Needle Biopsy Market is expanding as healthcare providers increasingly rely on minimally invasive tissue-sampling methods for cancer diagnosis and other disease evaluations. Advances in image-guided biopsy, specialized needles, robotic assistance, and personalized medicine are supporting market development.
According to the Market Research Future report updated September 15, 2026, the Needle Biopsy Market was valued at USD 2.35 billion in 2024 and is projected to grow from USD 2.46 billion in 2025 to USD 3.98 billion by 2035, registering a CAGR of 4.91% during 2025–2035. Technological advancements, minimally invasive procedures, and personalized medicine are major trends, while rising cancer incidence is creating additional demand.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.marketresearchfuture.com/reports/needle-biopsy-market-3830
Key players driving innovation and competitiveness in the Needle Biopsy Market include:
Becton Dickinson and Company
Boston Scientific Corporation
Medtronic plc
Hologic
Siemens Healthineers AG
The market is being shaped by increasing cancer diagnosis requirements and demand for less invasive sampling. Image-guided procedures are improving precision and enabling access to difficult anatomical sites.
The Needle Biopsy Market can be segmented by product type, application, guidance technology, end user, and region. Major applications include cancer diagnosis and disease evaluation, while hospitals, diagnostic centers, and specialty clinics represent important end users.
Opportunities are emerging through ultrasound-guided biopsy, robotic assistance, specialized needles, and integration with personalized medicine.
Recent Developments and Market Trends:
Ultrasound-guided biopsy is improving lesion targeting and procedure precision.
Robotic-assisted systems are supporting more controlled sampling.
Minimally invasive procedures are gaining preference because of shorter recovery times.
Personalized medicine is increasing the need for precise tissue samples.
Rising cancer incidence is sustaining demand for diagnostic biopsy procedures.
Reasons to Buy the Report:
Understand market size and forecast through 2035.
Analyze technology and application trends.
Identify major end-user opportunities.
Evaluate leading manufacturers.
Assess opportunities in image-guided and robotic biopsy.
Future Outlook:
The Needle Biopsy Market is expected to grow steadily as cancer diagnosis and personalized treatment increase. Image-guided and minimally invasive techniques will remain important growth areas, while advanced needles and robotic assistance can improve procedural precision. Overall, the market is projected to reach USD 3.98 billion by 2035 at a CAGR of 4.91%.
➤➤Explore Our Latest Related Reports:
